Serial biotech founder Tim Springer on investing in startups and democratizing antibody research

Tim Springer never dreamed he’d be spending as much time investing in biotechnology companies as on his academic pursuits.

Springer, after all, is a leading scientist in research on proteins known as “integrins.” For more than four decades at his Harvard University laboratory, he has studied the role the complex molecules play and how they might be targeted to treat disease.